ATE (ATE) Stock Price, News & Analysis

Name: ATE (ATE) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

ATE

Company Description

This page collects what Stock Titan holds for ATE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

March 3, 2021

—

Antibe Therapeutics to Present at Upcoming Virtual Investor Conferences

conferences

February 12, 2021

—

Antibe Therapeutics Reports Q3 2021 Interim Financial and Operating Results

earnings

February 9, 2021

—

Antibe Therapeutics Announces Strategic Licensing Deal in China With Nuance Pharma

January 7, 2021

—

Antibe Therapeutics Strengthens Partnering Advisory Team With Appointment of Don Haut

management

December 18, 2020

—

Antibe Therapeutics Announces Intent to Unify Intellectual Property Ownership

ATE has 5 recent news articles. Key topics include conferences, earnings, management. View all ATE news →

SEC Filings

View All

No SEC filings available for ATE.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months